James George Chopas Form 3 Radius Health / James George Chopas ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Chopas James George

(Last) (First) (Middle)

C/O RADIUS HEALTH, INC.

950 WINTER STREET

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/15/2020

3. Issuer Name and Ticker or Trading Symbol
Radius Health, Inc. [ RDUS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Principal Finance Accounting

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,492	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	11/15/2028	Common Stock	17,500	16.12	D
Stock Option (Right to Buy)	(2)	03/02/2030	Common Stock	6,500	20.25	D
Stock Option (Right to Buy)	(3)	11/09/2030	Common Stock	26,000	14.08	D
Restricted Stock Units(4)	(5)	(6)	Common Stock	3,500	0.00	D

Explanation of Responses:

1. 25% of the shares subject to this stock option vested on November 15, 2019; and the remaining shares have vested or shall vest in substantially equal monthly installments over 36 months thereafter.

2. 25% of the shares subject to this stock option will vest on March 2, 2021; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.

3. 25% of the shares subject to this stock option shall vest on November 9, 2021; and the remaining shares shall vest in substantially equal monthly installments over 36 months thereafter.

4. Each Restricted Stock Unit represents a contingent right to receive one share of common stock.

5. This Restricted Stock Unit grant shall vest as to 33.33% on March 2, 2021; and as to 33.33% annually thereafter over the following two years on March 2 of each year.

6. Not applicable.

Remarks:

	/s/ Nathan N. McConarty, as attorney-in-fact	12/18/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.